Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigenobu Emoto

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
International Journal of Clinical Oncology|January 24, 2026
Circulating tumor DNA methylation and gut microbiota in colorectal cancer: diagnostic, prognostic, and therapeutic implicationsKazuhito Sasaki, Shigenobu Emoto, Yuichiro Yokoyama, et al.
Case Reports in Oncology|February 28, 2014
Intraperitoneal Paclitaxel is useful as adjuvant chemotherapy for advanced gastric cancer with serosal exposureJoji Kitayama, Hironori Ishigami, Hironori Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 14, 2012
[Multidisciplinary treatment for gastric cancer with peritoneal metastasis]Hironori Ishigami, Joji Kitayama, Hironori Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 10, 2013
[Multidisciplinary treatment strategy for gastric cancer with peritoneal metastasis]Hironori Ishigami, Joji Kitayama, Hironori Yamaguchi, et al.
Annals of Surgical Oncology|September 14, 2014
Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal disseminationShigenobu Emoto, Joji Kitayama, Hironori Ishigami, et al.
Cancer Chemotherapy and Pharmacology|January 28, 2014
Intraperitoneal paclitaxel induces regression of peritoneal metastasis partly by destruction of peripheral microvesselsJoji Kitayama, Shigenobu Emoto, Hironori Yamaguchi, et al.
Plos One|January 28, 2014
CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironmentJoji Kitayama, Shigenobu Emoto, Hironori Yamaguchi, et al.
Cancer Science|March 21, 2012
Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal disseminationShigenobu Emoto, Hironori Yamaguchi, Junko Kishikawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 14, 2011
Frequent development of leptomeningeal carcinomatosis in patients with peritoneal dissemination of gastric cancerShigenobu Emoto, Hironori Ishigami, Hironori Yamaguchi, et al.
International Journal of Surgery Case Reports|April 12, 2023
Multiple ulcers and perforation of small intestine with everolimus use in a patient with rectal neuroendocrine tumor: A case reportKentaro Abe, Shigenobu Emoto, Kazuhito Sasaki, et al.
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
International Journal of Clinical Oncology|January 24, 2026
Circulating tumor DNA methylation and gut microbiota in colorectal cancer: diagnostic, prognostic, and therapeutic implicationsKazuhito Sasaki, Shigenobu Emoto, Yuichiro Yokoyama, et al.
Case Reports in Oncology|February 28, 2014
Intraperitoneal Paclitaxel is useful as adjuvant chemotherapy for advanced gastric cancer with serosal exposureJoji Kitayama, Hironori Ishigami, Hironori Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 14, 2012
[Multidisciplinary treatment for gastric cancer with peritoneal metastasis]Hironori Ishigami, Joji Kitayama, Hironori Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 10, 2013
[Multidisciplinary treatment strategy for gastric cancer with peritoneal metastasis]Hironori Ishigami, Joji Kitayama, Hironori Yamaguchi, et al.
Annals of Surgical Oncology|September 14, 2014
Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal disseminationShigenobu Emoto, Joji Kitayama, Hironori Ishigami, et al.
Cancer Chemotherapy and Pharmacology|January 28, 2014
Intraperitoneal paclitaxel induces regression of peritoneal metastasis partly by destruction of peripheral microvesselsJoji Kitayama, Shigenobu Emoto, Hironori Yamaguchi, et al.
Plos One|January 28, 2014
CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironmentJoji Kitayama, Shigenobu Emoto, Hironori Yamaguchi, et al.
Cancer Science|March 21, 2012
Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal disseminationShigenobu Emoto, Hironori Yamaguchi, Junko Kishikawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 14, 2011
Frequent development of leptomeningeal carcinomatosis in patients with peritoneal dissemination of gastric cancerShigenobu Emoto, Hironori Ishigami, Hironori Yamaguchi, et al.
International Journal of Surgery Case Reports|April 12, 2023
Multiple ulcers and perforation of small intestine with everolimus use in a patient with rectal neuroendocrine tumor: A case reportKentaro Abe, Shigenobu Emoto, Kazuhito Sasaki, et al.
Pageof 18